Mivium develops a patented manufacturing process to produce high‑purity GaN (gallium nitride) substrates and particles, aiming to overcome supply‑chain and cost barriers in GaN production. The company says its process is scalable, cost‑effective and avoids the toxic byproducts associated with conventional methods. Mivium’s immediate product focus is a GaN particle prototype, with plans to follow by bringing GaN substrates to market. Target end markets cited include AI data centers, electric vehicles, aerospace/defense, telecommunications, photonics and biotechnology. The company highlights its team of material science and semiconductor manufacturing experts driving technology development. As of the announced financing, Mivium has raised a total of over $6.34 million.

Total raised

$5M

Funding rounds

1

Latest round

Equity

Latest activity

May 2025